RPG Life Sciences Limited (RPGLIFE.NS)
INR 2267.75
(3.54%)
INR 2267.75
(3.54%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | 5.82 Billion | 5.12 Billion | 4.37 Billion | 3.83 Billion | 3.69 Billion | 3.23 Billion |
| Cost of Revenue | 3.33 Billion | 1.7 Billion | 1.5 Billion | 1.37 Billion | 1.27 Billion | 1.1 Billion |
| Gross Profit | 2.48 Billion | 3.41 Billion | 2.86 Billion | 2.45 Billion | 2.41 Billion | 2.13 Billion |
| Operating Expenses | 1.63 Billion | 2.54 Billion | 2.15 Billion | 1.91 Billion | 1.97 Billion | 1.94 Billion |
| Selling, General and Administrative Expenses | 1.54 Billion | 537.9 Million | 519.3 Million | 379.3 Million | 329.7 Million | 281.1 Million |
| Research and Development Expenses | 93.6 Million | 89.3 Million | 89.7 Million | 88.8 Million | 93.3 Million | 75 Million |
| Other Expenses | - | 48 Million | 29.9 Million | 1 Million | 1.64 Billion | 3.7 Million |
| Cost and Expenses | 3.52 Billion | 4.25 Billion | 3.65 Billion | 3.28 Billion | 3.24 Billion | 3.04 Billion |
| Operating Income | 2.29 Billion | 881 Million | 707.4 Million | 536.6 Million | 429.5 Million | 191.9 Million |
| Interest Expense | 4.5 Million | 3.1 Million | 5.2 Million | 7.9 Million | 17.5 Million | 39.9 Million |
| Income Tax Expense | 301.8 Million | 240.4 Million | 216.9 Million | 135.8 Million | 74.4 Million | 42.4 Million |
| Earnings before Tax | 1.17 Billion | 916.8 Million | 731.7 Million | 535.8 Million | 364.5 Million | 150.5 Million |
| Net Income | 876.6 Million | 676.4 Million | 514.8 Million | 400 Million | 290.1 Million | 108.1 Million |
| Earnings Per Share Basic | 53.00 | 40.90 | 31.13 | 24.19 | 17.54 | 6.54 |
| Earnings Per Share Diluted | 53.00 | 40.90 | 31.13 | 24.19 | 17.54 | 6.54 |
| Weighted Average Shares Outstanding | 16.53 Million | 16.53 Million | 16.53 Million | 16.53 Million | 16.53 Million | 16.53 Million |
| Weighted Average Shares Outstanding (Diluted) | 16.53 Million | 16.53 Million | 16.53 Million | 16.53 Million | 16.53 Million | 16.53 Million |
| Gross Margin | 0.43 | 0.67 | 0.66 | 0.64 | 0.65 | 0.66 |
| EBIT Margin | 0.22 | 0.42 | 0.20 | 0.19 | 0.16 | 0.11 |
| Profit Margin | 0.15 | 0.13 | 0.12 | 0.10 | 0.08 | 0.03 |
| EBITDA | 1.28 Billion | 1.08 Billion | 902.4 Million | 718.4 Million | 555.7 Million | 352.3 Million |
| Earnings Before Tax Margin | 0.39 | 0.17 | 0.16 | 0.14 | 0.12 | 0.06 |
| Breakdown | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 |
|---|---|---|---|---|---|---|
| Revenue | 1.65 Billion | 5.82 Billion | 1.26 Billion | 1.53 Billion | 1.53 Billion | 1.47 Billion |
| Cost of Revenue | 930.4 Million | 3.33 Billion | 780.1 Million | 481.7 Million | 447.4 Million | 871.8 Million |
| Gross Profit | 723.8 Million | 2.48 Billion | 489.8 Million | 1.05 Billion | 1.08 Billion | 606 Million |
| Operating Expenses | 386 Million | 1.37 Billion | 327.5 Million | 717.7 Million | 757.8 Million | 325.7 Million |
| Selling, General and Administrative Expenses | 386 Million | - | 327.5 Million | 339.4 Million | 379.6 Million | 325.7 Million |
| Research and Development Expenses | - | - | 93.6 Million | - | - | - |
| Other Expenses | 23.7 Million | 72.1 Million | 16.5 Million | 19.2 Million | 18.3 Million | - |
| Cost and Expenses | 1.31 Billion | 4.7 Billion | 1.1 Billion | 1.19 Billion | 1.2 Billion | 1.19 Billion |
| Operating Income | 337.8 Million | 1.11 Billion | 162.3 Million | 356.8 Million | 348.9 Million | 280.3 Million |
| Interest Expense | 1.5 Million | 4.5 Million | 1.4 Million | 1.4 Million | 1 Million | 700 Thousand |
| Income Tax Expense | 92.4 Million | 301.8 Million | 45 Million | 90.8 Million | 89.3 Million | 76.7 Million |
| Earnings before Tax | 360 Million | 1.17 Billion | 177.4 Million | 355.4 Million | 347.9 Million | 297.7 Million |
| Net Income | 267.6 Million | 876.6 Million | 132.4 Million | 264.6 Million | 258.6 Million | 221 Million |
| Earnings Per Share Basic | 16.18 | - | 8.01 | 16.00 | 15.64 | 13.36 |
| Earnings Per Share Diluted | 16.18 | - | 8.01 | 16.00 | 15.64 | 13.36 |
| Weighted Average Shares Outstanding | 16.53 Million | 16.53 Million | 16.52 Million | 16.53 Million | 16.53 Million | 16.53 Million |
| Weighted Average Shares Outstanding (Diluted) | 16.53 Million | 16.53 Million | 16.52 Million | 16.53 Million | 16.53 Million | 16.53 Million |
| Gross Margin | 0.44 | 0.43 | 0.39 | 0.69 | 0.71 | 0.41 |
| EBIT Margin | 0.24 | - | 0.16 | 0.26 | 0.25 | 0.22 |
| Profit Margin | 0.16 | 0.15 | 0.10 | 0.17 | 0.17 | 0.15 |
| EBITDA | 390.7 Million | - | 207.2 Million | 398.2 Million | 391.2 Million | 322.4 Million |
| Earnings Before Tax Margin | 0.20 | 0.19 | 0.13 | 0.23 | 0.23 | 0.19 |
GOACARBON
ESSITY-A
THYROCARE
COFORGE
PRB
TBLT